Mini review · 13 Apr 2026
Conference abstractPublished 3 Sep 2015
Substantial weight loss in 237 hypogonadal men with obesity class I-III under long-term treatment with testosterone undecanoate (TU): Observational real-life data from a registry study
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Testosterone (T) and obesity are inversely associated. Obesity has a greater impact on T decrease than advancing age. Methods: Single-center, prospective, cumulative registry study of 340 hypogonadal men (total T ≤12.1 nmol/L and presence of symptoms). 237 men with obesity class I-III were analyzed. All men received TU injections every 3 months for up to 7 years. Anthropometric parameters were measured at every 3-monthly visit. Results: Class I (n=103, mean age: 58 years): Weight decreased from 102.79 to 85.41 kg by 17.27 kg, per cent change from baseline -16.71%. Waist circumference (WC) decreased from 104.74 to 95.24 cm by 8.93 cm. BMI decreased from 32.85 to 27.65 kg/m2 by 5.5 kg/m2. Class II (n=97, mean age: 60 years): Weight decreased from 116.67 to 92.19 kg by 25.15 kg, per cent change from baseline -21.52%. WC decreased from 111.97 to 100.96 cm by 12.53 cm. BMI decreased from 37.33 to 29.88 kg/m2 by 8.06 kg/m2. Class III (n=36, mean age: 60 years): Weight decreased from 128.92 to 100.75 kg by 29.3 kg, per cent change from baseline -22.79%. WC decreased from 117.56 to 103.63 cm by 12.93 cm. BMI decreased from 41.99 to 33.23 kg/m2 by 9.59 kg/m2. No patient gained or re-gained weight. No patient dropped out. There were no major adverse cardiovascular events during the entire observation period. Conclusions: All changes were clinically meaningful and sustained for the full observation period. T therapy is an effective approach to achieve sustained weight loss in obese hypogonadal men, thereby potentially reducing cardiometabolic risk.
Subjects
Obesity & Weight ManagementAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Obesity & Weight Loss Therapy.
Research article · 27 Feb 2026
Modulation of Postprandial GLP-1 Secretion and Glycemic Responses by a Food-Grade GLP-1 Formula in Human Subjects
Short communication · 9 Feb 2026
Intensive Blood Pressure Lowering Target Guided by Home Blood Pressure Monitoring for Hypertensive Patients with Type 2 Diabetes, Which is Better or Not
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Obesity & Weight Loss Therapy
- SubjectObesity & Weight Management
- BylineArticles whose byline prints “Farid Saad”